-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
X4 Pharmaceuticals, Inc annual and quarterly Amortization of Intangible Assets in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
- X4 Pharmaceuticals, Inc Amortization of Intangible Assets for the quarter ending 30 Sep 2024 was $200,000.
- X4 Pharmaceuticals, Inc annual Amortization of Intangible Assets for 2024 was $500,000.
- X4 Pharmaceuticals, Inc annual Amortization of Intangible Assets for 2023 was $0.